In this episode recorded at LongevityFest, hosts Tom Blue and Sonia Horner welcome Dr. Don Brown, the serial physician-entrepreneur and former founder of LifeOmic, to unveil his latest venture: Bioscope.ai. Dr. Brown discusses how the plummeting cost of whole genome sequencing combined with the explosion of generative AI has allowed him to build the "AI Medical Colleague" he predicted years ago. The group explores how Bioscope.ai aggregates massive datasets—from 30x whole genome sequencing to multi-omics and EMRs—into a secure "synoptic view" that visualizes a patient's health across 15 dimensions. The conversation highlights how this technology enables a new class of subscription-based medicine by turning static medical records into dynamic, living health assets that evolve with the patient.
The Convergence of Cost and Tech: Dr. Brown explains that the drop in whole genome sequencing costs (from $1,000 to ~$300) and the rise of LLMs created the perfect storm to launch a platform that can affordably integrate germline DNA, microbiomes, and EMR data for primary care.
The "Orchestration Layer": Rather than relying on a single AI model, Bioscope.ai uses a "committee" of leading LLMs. Critically, these models are grounded in truth via an API from Scite (accessing ~100 million academic papers) and curated NIH datasets like ClinVar and Mondo to prevent hallucinations.
The Synoptic View: Inspired by aviation systems, the platform interface utilizes a 3D wireframe of the patient body and analyzes 15 distinct dimensions of health (e.g., metabolic, neurocognitive, cardiovascular), offering clinicians a real-time "green-yellow-red" status for each system.
Dynamic Personalization: The platform features "Lumina," an AI persona that learns the specific "theory of mind" of the clinician—understanding their functional medicine training and communication style—to act as a true digital extension of the doctor.
The "Living Asset" Value Proposition: Tom Blue argues that practitioners can use Bioscope.ai to justify high-value membership models. Unlike standard lab testing which results in a static PDF that gets filed away, this platform turns patient data into a "digital health asset" that is constantly re-interpreted against new science, providing ongoing value "between the visits".
Context as a Differentiator: By 2026, practices will need to differentiate their AI capabilities. The winning strategy will be having the largest "window of context" around a patient. Bioscope provides this by aggregating everything from unstructured notes to proteomics in one secure place.
Deploying the "Super Team": Practitioners can look forward to utilizing specific AI personas for different tasks. Beyond the physician-facing "Lumina," the system can deploy patient-facing personas (like a nurse, physical therapist, or dietician) to help patients execute care plans daily.
Bioscope.ai: The central hub for the platform.
"Try It On Yourself": Dr. Brown announces a program for physicians to experience the platform using their own data before deploying it to patients. Interested practitioners can sign up at Bioscope.ai.
Resource: Visit the Innovations in Clinical Implementation landing page for exclusive resources.
High-Performance Aircraft: Dr. Brown compares the Bioscope.ai interface to the "synoptic view" used in fighter jets. Just as a pilot needs a visual representation of hydraulics, fuel, and engines to see problems instantly, a doctor needs a visual dashboard of the body's physiological systems rather than a list of text.
The AI Colleague: The platform is not designed as a tool like a calculator, but as a "colleague" that has a personality, learns your work style, and understands your values over time.
Dr. Don Brown, MD is a physician, technologist, and entrepreneur currently serving as Founder and CEO of Bioscope.AI, where he focuses on applying AI and multi-omics to advance primary care medicine. He has founded and led multiple technology companies, including Software Artistry, Interactive Intelligence, and LifeOmic, with two companies completing IPOs and subsequent acquisitions by IBM, Genesys, and Fountain Life. His work spans software development, genomics, and healthcare data platforms. Don holds degrees in physics and computer science, an MD from Indiana University School of Medicine, and a master’s in biotechnology from Johns Hopkins University. He is an active investor and philanthropist, donating $30 million to establish the Brown Immunotherapy Center at Indiana University School of Medicine, and is the author of Understanding Life (2022).
Sonja Harrison Horner is a healthcare executive with over 20 years of experience advancing innovation across chronic disease regression, functional and integrative medicine, and healthcare delivery transformation. Her work focuses on utilization strategy, healthcare consumerism, and improving patient engagement and outcomes. Sonja has held strategic advisory roles with insurance trusts, self-funded employers, and organizations operating within government-funded programs. As Founder and CEO of LeadHealth, she pioneered the integration of functional medicine into employer-sponsored health strategies through a virtual network of IFM-certified physicians. She is also Co-founder and President of n1Health, where she developed strategies that helped transition insurance-based practices into retirement assets for physician partners. Sonja advises healthcare startups on direct-to-consumer strategy and operational execution, advancing scalable, patient-centered care models.
Tom Blue is a Founding Partner of OvationLab, a business advisory and clinical research firm that helps companies in natural products, testing, digital health, and medical devices successfully launch and commercialize within the healthcare professional channel. Since establishing Virginia’s first concierge medical practice in 2001, he has focused on designing and implementing innovative practice models that accelerate the translation of emerging best practices into real-world care. His latest venture, AndHealth—a root-cause, largely virtual clinical model backed in part by the AMA’s investment arm—closed the largest seed round in digital health in 2021 at $57M. Tom’s current work centers on the rapidly evolving longevity marketplace, clinical applications of AI, and scaling personalized nutritional supplementation.